Calnexin Antibody, mAb, Rabbit
| $210.00 | |
| A03222-50 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $210.00 | |
| A03222-50 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Specificity | This product is specific to Calnexin |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human Calnexin |
| Species Reactivity | Human; Rat |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||
|
|||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
All lanes use Calnexin Antibody, mAb, Rabbit at 1:1K dilution for 1 hour at room temperature. »
| Target Background | Calnexin is a calcium-binding protein embedded in the ER membrane that retains the newly synthesized glycoproteins inside the ER to ensure proper folding and quality control. The specificity of calnexin for a subset of glycoproteins is defined by a lectin site, which binds an early oligosaccharide intermediate on the folding glycoprotein. |
| Synonyms | Calnexin; CANX; CNX; IP90; Major histocompatibility complex class I antigen-binding protein p88; p90; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.